Effects of cytochrome P450 inhibitors on potassium currents and mechanical activity in rat portal vein

British Journal of Pharmacology

Volumn 119, Issue 4, 1996, Pages 691-701

  Edwards, Gillian ^a   Zygmunt, Peter M ^a   Högestätt, Edward D ^b   Weston, Arthur H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

17 ODYA; BK(Ca); Clotrimazole; Cytochrome P450; EDHF; K(ATP); K currents; Proadifen; Rat portal vein; Whole cell voltage clamp

Indexed keywords

CLOTRIMAZOLE; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENZYME INHIBITOR; LEMAKALIM; POTASSIUM CHANNEL; PROADIFEN; STEARIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MUSCLE ACTION POTENTIAL; NONHUMAN; PORTAL VEIN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SPASMOLYSIS; TIME; VENOCONSTRICTION;

EID: 0029907118     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15728.x     Document Type: Article

References (32)

1. + channels by cytochrome P-450 inhibitors. J. Biol. Chem., 267, 11789-11793.
2. BAUERSACHS, J., HECKER, M. & BUSSE, R. (1994). Display of the characteristics of endothelium-derived hyperpolarising factor by a cytochrome P450-derived arachidonic acid metabolite on the coronary microcirculation. Br. J. Pharmacol., 113, 1548-1553.
3. BEECH, D.J. & BOLTON, T.B. (1989). Properties of the cromakalim-induced potassium conductance in smooth muscle cells isolated from the rabbit portal vein. Br. J. Pharmacol., 98, 851-864.
4. CAMPBELL, W.B., GEBREMEDHIN, D., PRATT, P.F. & HARDER, D.R. (1996). Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ. Res., 78, 415-423.
5. COHEN, R.A. & VANHOUTTE, P.M. (1995). Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP. Circulation, 92, 3337-3349.
6. DALY, J.W., LUEDERS, J., PADGETT, W.L., SHIN, Y. & GUSOVSKY, F. (1995). Maitotoxin-elicited calcium influx in cultured cells - effect of calcium-channel blockers. Biochem. Pharmacol., 50, 1187-1197.
7. EDWARDS, G., IBBOTSON, T. & WESTON, A.H. (1993). Levcromakalim may induce a voltage-independent K-current in rat portal veins by modifying the gating properties of the delayed rectifier. Br. J. Pharmacol., 110, 1037-1048.
8. Ca channel opener, in rat portal vein. Br. J. Pharmacol., 113, 1538-1547.
9. EDWARDS, G. & WESTON, A.M. (1995). Potassium channels in the regulation of vascular smooth muscle tone. In Pharmacological Control of Calcium and Potassium Homeostasis: Biological, Therapeutic and Clinical Aspects. ed. Godfraind, T., Mancia, G., Abbracchio, M.P., Aguilar-Bryan, L. & Govoni, S. pp. 85-93. London: Kluwer Academic Publishers.
10. FURCHGOTT, R.F. (1993). The discovery of endothelium-dependent relaxation. Circulation, 87, 3-8.
11. GARLAND, C.J. & MCPHERSON, G.A. (1992). Evidence that nitric oxide does not mediate the hyperpolarisation and relaxation to acetylcholine in the rat small mesenteric artery. Br. J. Pharmacol., 105, 429-435.
12. GARLAND, C.J., PLANE, F., KEMP, B.K. & COCKS, T.M. (1995). Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol. Sci., 16, 23-30.
13. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
14. HARDER, D.R., CAMPBELL, W.B. & ROMAN, R.J. (1995). Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res., 32, 79-92.
15. HARDER, D.R., GEBREMEDHIN, D., NARAYANAN, J., JEFCOAT, C., FALCK, J.R., CAMPBELL, W.B. & ROMAN, R. (1994). Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am. J. Physiol., 266, H2098-H2107.
16. HECKER, M., BARA, A.T., BAUERSACHS, J. & BUSSE, R. (1994). Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J. Physiol., 481, 407-414.
17. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur. J. Pharmacol., 230, 215-221.
18. IBBOTSON, T., EDWARDS, G. & WESTON, A,H. (1993). Antagonism of levcromakalim by imidazoline-derivatives and guanidine-derivatives in rat portal vein - involvement of the delayed rectifier. Br. J. Pharmacol., 110, 1556-1564.
19. JACQZ-AIGRAIN, E., GUEGUEN, M., ZANGER, U.M., ROBIEUX, I. & ALVAREZ, F. (1991). Cytochrome P450IID in non-human primates. Catalytical and immunological characterization. Biochem. J., 41, 1657-1663.
20. KLÖCKNER, U. & ISENBERG, G. (1985). Action potentials and net membrane currents of isolated smooth muscle cells (urinary bladder of the guinea-pig). Pflügers Arch., 405, 329-339.
21. LISCHKE, V., BUSSE, R. & HECKER, M. (1995). Selective inhibition by barbiturates of the synthesis of endothelium-derived hyperpolarizing factor in the rabbit carotid artery. Br. J. Pharmacol., 115, 969-974.
22. NOACK, TH., DEITMER, P,M EDWARDS, G. & WESTON, A.H. (1992a). Characterization of potassium currents modulated by BRL38227 in rat portal vein. Br. J. Pharmacol., 106, 717-726.
23. NOACK, TH., EDWARDS, G., DEITMER, P., GREENGRASS, P., MORITA, T., ANDERSSON, P.O., CRIDDLE, D., WYLLIE, M.G. & WESTON, A.M. (1992b). The involvement of potassium channels in the action of ciclazindol in rat portal vein. Br. J. Pharmacol., 106, 17-24.
24. ORTIZ DE MONTELLANO, P.R. & CORREIA, M.A. (1995). Inhibition of cytochrome P450 enzymes. In Cytochrome P450. Structure, Mechanism and Biochemistry. ed. Ortiz de Montellano, P.R. pp. 305-364. New York: Plenum Press.
25. RUBART, M., PRESSLER, M.L., PRIDE, H.P. & ZIPES, D.P. (1993). Electrophysiological mechanisms in a canine model of erythromycin-associated long QT syndrome. Circulation, 88, 1832-1844.
26. + channels in follicle-enclosed Xenopus oocytes. Eur. J. Pharmacol., 251, 117-121.
27. TAYLOR, S.G. & WESTON, A.H. (1988). Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium. Trends Pharmacol. Sci., 9, 272-274.
28. 2+ entry into GH3 and chromaffin cells by imidazole antimycotics and other cytochrome P450 blockers. FASEB J., 6, 2742-2747.
29. ZOU, A.-P., IMIG, J.D., KALDUNSKI, M., ORTIZ DE MONTELLANO, P.R., SUI, Z. & ROMAN, R.J. (1994). Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol., 266, F275-F282.
30. ZYGMUNT, P.M., EDWARDS, G., WESTON, A.H., DAVIS, S.C. & HÖGESTÄTT, E.D. (1996a). Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery. Br. J. Pharmacol., 118, 1147-1152.
31. ZYGMUNT, P.M. & HÖGESTÄTT, E.D. (1966). Role of potassium channels in endothelium-dependent relaxation resistant to nitroarginine in the rat hepatic artery. Br. J. Pharmacol., 117, 1600-1606.
32. ZYGMUNT, P.M., HÖGESTÄTT, E.D., EDWARDS, G., ORTIZ DE MONTELLANO, P.R. & WESTON, A.H. (1996b). Effects of cytochrome P450 inhibitors on endothelium-dependent and levcromakalim-induced responses in rat blood vessels. Br. J. Pharmacol., 117, 120P.